Eirx Therapeutics PLC - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Eirx Therapeutics PLC. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Eirx Therapeutics PLC. The Group's principal activity is discovering and developing novel therapeutics for the treatment of cancer. It focuses on the study of cancer cell survival and growth, with a research base encompassing apoptosis biology, cancer biomarkers and the metabolic basis of drug resistance in tumours. The Group creates intellectual property that seeks to exploit through in-house product development and licensing.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report